Stay updated on Resmetirom Safety and Biomarkers Clinical Trial
Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated the document revision tag from v3.6.3 to v3.6.4, signaling a newer revision of the page rather than a substantive content change.SummaryDifference0.0%

- Check18 days agoChange DetectedSteatotic Liver Disease was added to the list of related terms on the page, and Fatty Liver Disease was removed. This updates the page's terminology to reflect current disease nomenclature and enhances clarity for readers and indexing.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the published version. It does not appear to modify visible content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page’s revision history shows a new version, v3.6.2, replacing the previous v3.6.0, indicating an update to the page’s revision metadata rather than changes to trial details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe study record metadata and indexing keywords, including MeSH terms, sponsor/investigator notes, and location information, have been removed. This changes how the trial is described and found on the site.SummaryDifference17%

- Check53 days agoChange DetectedThe study page now indicates that recruitment is closed ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label is added and the Intervention / Treatment label is removed, with the site revision note updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.